Author: OurCrowd

[Swiftly in Business Wire] Swiftly collaborates with ExtraMile Convenience Stores LLC to launch digital alcohol cashback in ExtraMile® Mobile App

Jan 22, 2026 |

SEATTLE–(BUSINESS WIRE)–Swiftly, a leading provider of retail technology and retail media solutions, today announced that it is working with ExtraMile Convenience Stores LLC to integrate Swiftly’s Alcohol Cashback program into the ExtraMile, Chevron and Texaco mobile apps and the combined rewards program. The launch introduces a fully digital, seamless savings experience on beer, wine, and spirits for shoppers that are rewards members across more than 1,100 ExtraMile locations in the United States. Read more...

Read More

[Taranis in PR Newswire] SiFly and Taranis launch field validation program to accelerate aerial crop intelligence at scale

Jan 21, 2026 |

SANTA CLARA, Calif. and WESTFIELD, Ind., Jan. 21, 2026 /PRNewswire/ — SiFly Aviation, Inc., a U.S.-based manufacturer of long-endurance autonomous VTOL drones, and Taranis, a U.S.-based leader in AI-powered, leaf-level crop intelligence, today announced the launch of a joint 2026 Field Validation Program focused on validating a new operational model for large-scale aerial crop intelligence. Read...

Read More

[BrightInsight in BrightInsight] BrightInsight announces multi-million dollar strategic investment to advance its AI-enabled medication persistence and adherence Solutions

Jan 20, 2026 |

SAN JOSE, Calif., – January 20, 2026 (Globe Newswire) – BrightInsight, Inc., a leader in digital health solutions, today announced a new investment round of $13 million from existing and new investors including Eclipse, General Catalyst, Insight Partners, Mayo Clinic, and New Leaf Venture Partners. This new capital will accelerate development of BrightInsight’s AI-enabled medication persistence and adherence solutions and enable rapid scalability of high-impact programs, such as the Patient App from its collaboration with Sanofi and their partner, Regeneron, across a broad range of diseases and therapies globally. Read...

Read More